Advances in Precision Cancer Care for Community Practitioners: A Focus on NTRK- and RET-Altered Malignancies

Download All
Download slides and view an on-demand webcast from a live meeting on recent advances in treating patients with cancer in the community setting who have NTRK- and RET-altered malignancies.
Alexander Drilon, MD
Program Director
Thomas Stinchcombe, MD
Program Director
person default
Saad A. Khan, MD

Downloadable Slideset

Download this slideset on the management of NTRK and RET-altered malignancies with targeted therapies.

Alexander Drilon, MD
Program Director
Thomas Stinchcombe, MD
Program Director
Released: August 4, 2022

On-Demand Webcast

Watch this on-demand webcast of a live CCO webinar to gain expert insight on managing NTRK- and RET-altered malignancies, including optimal methods for detecting gene fusions.

Alexander Drilon, MD
Program Director
Thomas Stinchcombe, MD
Program Director
person default Saad A. Khan, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 10, 2022 Expired: June 9, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Genentech, a member of the Roche Group
Lilly

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings